Publication: The Criminalization of Innovation: FDA Misdirection in the Najarian and Burzynski Cases
Open/View Files
Date
1997
Authors
Published Version
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
The Criminalization of Innovation: FDA Misdirection in the Najarian and Burzynski Cases (1997 Third Year Paper)
Research Data
Abstract
Najarian and Burzynski seem the perfect examples of the amazing potential of the American medical establishment. Their visionary work in their respective fields should be celebrated as monumental contributions to society. Rather than being lauded by the nation, though, both men have watched their careers and reputations come hurtling to a disastrous end as they faced criminal charges of fraud, embezzlement, and multiple violations of Food and Drug Administration (FDA) laws which threatened to send them each to prison for the rest of their lives.
Description
Other Available Sources
Keywords
Food and Drug Law, FDA misdirection, regulation of physician prescribing, human drugs, Najarian, Burzynski
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service